"alpha-Synuclein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.
| Descriptor ID |
D051844
|
| MeSH Number(s) |
D12.776.631.860.500 D12.776.637.500
|
| Concept/Terms |
alpha-Synuclein- alpha-Synuclein
- alpha Synuclein
- Non-AB Component of AD Amyloid Protein
- Non AB Component of AD Amyloid Protein
|
Below are MeSH descriptors whose meaning is more general than "alpha-Synuclein".
Below are MeSH descriptors whose meaning is more specific than "alpha-Synuclein".
This graph shows the total number of publications written about "alpha-Synuclein" by people in this website by year, and whether "alpha-Synuclein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 10 | 4 | 14 |
| 2018 | 12 | 4 | 16 |
| 2019 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "alpha-Synuclein" by people in Profiles.
-
The Intersection of Parkinson's Disease, Viral Infections, and COVID-19. Mol Neurobiol. 2021 Sep; 58(9):4477-4486.
-
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem Biophys Res Commun. 2021 05 21; 554:94-98.
-
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms. J Neurol. 2021 Sep; 268(9):3116-3124.
-
COVID-19 and selective vulnerability to Parkinson's disease. Lancet Neurol. 2020 09; 19(9):719.
-
Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease. Mov Disord. 2020 09; 35(9):1495-1496.
-
The Possible Protective Role of a-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease. Mov Disord. 2020 08; 35(8):1293-1294.
-
Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson's Disease. Int J Mol Sci. 2019 May 11; 20(9).
-
Involvement of C/EBPß-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis. Toxicol Lett. 2019 Sep 15; 312:11-21.
-
Autoimmunity in Parkinson's Disease: The Role of a-Synuclein-Specific T Cells. Front Immunol. 2019; 10:303.
-
Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain. 2019 02 01; 142(2):249-254.